Sign in
Enrolling by invitationNo phase

Phone app to support people managing venous thromboembolism

Tests a phone app for adults with venous thromboembolism and their views on prevention.

Key facts

Who runs it
Navy General Hospital, Beijing
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management
Status
Enrolling by invitation
People taking part
256 people, planned
Started
17 Aug 2024
Planned end
30 Nov 2025
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • mobile venous thromboembolism application (mVTEA)
Record updated
31 May 2025

Who can take part

The trial is looking for adults in hospital who have had a blood clot in a vein (DVT or PE), or who are at high risk of one when they leave hospital. It tests a mobile app that helps manage blood clots after discharge.

Age
18 years and older at admission
Sex
All sexes
Disease stage
A past or current clot in a deep vein (DVT) and/or in the lungs (PE), confirmed by imaging. Or a high risk of clots at discharge: Padua score ≥4 for medical patients, Caprini score ≥5 for surgical patients.
Main reasons for not taking part
  • A mental disorder or other serious illness that means the person cannot live independently
  • Not able to use smartphones, tablets or other smart devices
  • Being pregnant or breastfeeding
  • Having taken part in similar trials, or taking part in other clinical trials now
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • Inpatients ≥18 years of age at admission
  • Previous or current definitive diagnosis of DVT and/or PE by imaging, or at high risk of VTE at discharge: Padua score ≥4 for medical patients and Caprini score ≥5 for surgical patients
  • Signed informed consent

Who cannot take part

  • Mental disorder or combination of other serious diseases leading to incapacity for independent living
  • Inability to use smartphones, computer tablets and other smart devices
  • Being pregnant or breastfeeding
  • Have participated in similar trials or are undergoing other clinical trials

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Venous thromboembolism or digital health or health education

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Smart technologies, such as wearable devices, mobile technologies, and artificial intelligence, are being investigated for use in health management. These technologies have the potential to be applied in disease pre-warning, decision-making support, health education, and healthcare maintenance. They are expected to address the challenges in managing thrombosis, improve access to high-quality medical resources in various regions, and enhance the development of a network for thrombosis rescue and treatment prevention.

Read full original descriptionShow less

The objective of this study is to evaluate the impact of mobile venous thromboembolism application (mVTEA) based patient-centered management of venous thromboembolism (VTE) on patients' perceptions of thromboprophylaxis, in order to enhance clinical practice and establish a foundation of evidence for managing patients with VTE.

The 2 groups in the trial

  • mVTEA Management GroupTreatment being tested

    Patients randomly assigned to the mVTEA management group will be discharged with mVTEA-assisted patient-centered VTE management.

    Treatment: mobile venous thromboembolism application (mVTEA)

  • Routine Management GroupNo study treatment, for comparison

    Patients randomly assigned to the routine management group will be given routine post-discharge management in accordance with local clinical practice.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management: A Randomised Controlled Trial
Plain-language title
Phone app to support people managing venous thromboembolismGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT06350331, who can take part
Publications
Record updated
31 May 2025